Literature DB >> 10732763

Hepatocyte growth factor modulates motility and invasiveness of ovarian carcinomas via Ras-mediated pathway.

Y Ueoka1, K Kato, Y Kuriaki, S Horiuchi, Y Terao, J Nishida, H Ueno, N Wake.   

Abstract

Hepatocyte growth factor (HGF) is a multifunctional growth factor which has pleiotrophic biological effects on epithelial cells such as proliferation, motogenesis, invasiveness and morphogenesis. Peritoneal dissemination is critical for the progression of ovarian cancer, and our study revealed that HGF induces migration and invasion of ovarian cancer cells. We also demonstrated that HGF stimulates autophosphorylation of its receptor, followed by activation of the Ras-MAP (mitogen-activated peptide) kinase cascade. Moreover, infection of ovarian cancer cells with Ras dominant-negative adenovirus reduced the HGF-induced motogenic and invasive activities. Additionally, both MEK and P13-kinase pathways downstream of Ras were involved in HGF-stimulated ovarian cancer cell invasiveness.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10732763      PMCID: PMC2374409          DOI: 10.1054/bjoc.1999.1016

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  21 in total

1.  A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family.

Authors:  C Ponzetto; A Bardelli; Z Zhen; F Maina; P dalla Zonca; S Giordano; A Graziani; G Panayotou; P M Comoglio
Journal:  Cell       Date:  1994-04-22       Impact factor: 41.582

2.  Scatter factor is a fibroblast-derived modulator of epithelial cell mobility.

Authors:  M Stoker; E Gherardi; M Perryman; J Gray
Journal:  Nature       Date:  1987 May 21-27       Impact factor: 49.962

3.  Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript.

Authors:  A Moghul; L Lin; A Beedle; A Kanbour-Shakir; M C DeFrances; Y Liu; R Zarnegar
Journal:  Oncogene       Date:  1994-07       Impact factor: 9.867

4.  Enhanced tumorigenicity and invasion-metastasis by hepatocyte growth factor/scatter factor-met signalling in human cells concomitant with induction of the urokinase proteolysis network.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

5.  p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.

Authors:  M G Teneriello; M Ebina; R I Linnoila; M Henry; J D Nash; R C Park; M J Birrer
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

6.  Role of activated protein C in facilitating basement membrane invasion by tumor cells.

Authors:  H Kobayashi; N Moniwa; J Gotoh; M Sugimura; T Terao
Journal:  Cancer Res       Date:  1994-01-01       Impact factor: 12.701

7.  The motility signal of scatter factor/hepatocyte growth factor mediated through the receptor tyrosine kinase met requires intracellular action of Ras.

Authors:  G Hartmann; K M Weidner; H Schwarz; W Birchmeier
Journal:  J Biol Chem       Date:  1994-09-02       Impact factor: 5.157

8.  Overexpression of the Met/HGF receptor in ovarian cancer.

Authors:  M F Di Renzo; M Olivero; D Katsaros; T Crepaldi; P Gaglia; P Zola; P Sismondi; P M Comoglio
Journal:  Int J Cancer       Date:  1994-09-01       Impact factor: 7.396

9.  Signaling pathways in Ras-mediated tumorigenicity and metastasis.

Authors:  C P Webb; L Van Aelst; M H Wigler; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor.

Authors:  R Montesano; K Matsumoto; T Nakamura; L Orci
Journal:  Cell       Date:  1991-11-29       Impact factor: 41.582

View more
  16 in total

1.  Transcriptional gene expression profiles of HGF/SF-met signaling pathway in colorectal carcinoma.

Authors:  Xue-Nong Li; Yan-Qing Ding; Guo-Bing Liu
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

2.  α-Syntrophin is required for the hepatocyte growth factor-induced migration of cultured myoblasts.

Authors:  Min Jeong Kim; Stanley C Froehner; Marvin E Adams; Hye Sun Kim
Journal:  Exp Cell Res       Date:  2011-10-06       Impact factor: 3.905

3.  Fas ligand enhances malignant behavior of tumor cells through interaction with Met, hepatocyte growth factor receptor, in lipid rafts.

Authors:  Huan-Ching Lin; Po-Yin Lai; Yu-ping Lin; Jyun-Yuan Huang; Bei-Chang Yang
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

4.  Focal adhesion kinase and Src phosphorylations in HGF-induced proliferation and invasion of human cholangiocarcinoma cell line, HuCCA-1.

Authors:  Urai Pongchairerk; Jun-Lin Guan; Vijittra Leardkamolkarn
Journal:  World J Gastroenterol       Date:  2005-10-07       Impact factor: 5.742

Review 5.  Regulation of HGF and c-MET Interaction in Normal Ovary and Ovarian Cancer.

Authors:  Youngjoo Kwon; Andrew K Godwin
Journal:  Reprod Sci       Date:  2016-09-27       Impact factor: 3.060

6.  Rab17 inhibits the tumourigenic properties of hepatocellular carcinomas via the Erk pathway.

Authors:  Kejia Wang; Zhujun Mao; Li Liu; Ronghua Zhang; Qing Liang; Yaokang Xiong; Wenjun Yuan; Li Wei
Journal:  Tumour Biol       Date:  2015-02-24

7.  Proliferation and invasion: plasticity in tumor cells.

Authors:  Chong-Feng Gao; Qian Xie; Yan-Li Su; Julie Koeman; Sok Kean Khoo; Margaret Gustafson; Beatrice S Knudsen; Rick Hay; Nariyoshi Shinomiya; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-15       Impact factor: 11.205

8.  Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-catenin.

Authors:  Matthew H Herynk; Rachael Tsan; Robert Radinsky; Gary E Gallick
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

9.  Differential effects of cellular fibronectin and plasma fibronectin on ovarian cancer cell adhesion, migration, and invasion.

Authors:  Ladan Zand; Feng Qiang; Calvin D Roskelley; Peter C K Leung; Nelly Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Mar-Apr       Impact factor: 2.416

Review 10.  Slit/Robo pathway: a promising therapeutic target for cancer.

Authors:  Rishi K Gara; Sonam Kumari; Aditya Ganju; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2014-09-20       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.